Latest Biotechnology, Pharmaceutical and Healthcare News from Marketwired
Here are the most relevant search results for "Marketwired" found in our extensive news archives from over 250 global news sources.
More Information about Marketwired on BioPortfolio
In addition to our news stories we have dozens of PubMed Articles about Marketwired for you to read. Along with our medical data and news we also list Marketwired Clinical Trials, which are updated daily. BioPortfolio also has a large database of Marketwired Companies for you to search.
Showing News Articles 1–25 of 4,300+ from Marketwired
Deep Tours and Travels Chooses Assist America for Global Emergency Assistance Services
MUMBAI, INDIA -- (Marketwired) -- 05/22/13 -- Deep Tours and Travels (DTT), a Mumbai based IATA approved proprietor travel firm, announced today that it has partnered with Assist America to provide global emergency assistance services to its members. Effective immediately, Assist America will support DTT's members in India with services including medical referral and monitoring, emergency medic...
Functional Technologies to Apply for Extension of Creditor Protection Period
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/22/13 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") reports that it intends to make court application for an extension of the initial 30 day creditor protection period reported in the Company's news release of April 25, 2013. The Company also reports that Maurice Boucher has resigned from his consulting positions with the...
ORLANDO, FL -- (Marketwired) -- 05/22/13 -- Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced that optical biopsies using a microscope so tiny it fits through a small needle show clear cellular-level images inside pancreatic cysts, which could assist physicians in the diagnosis of pancreat...
NAPA, CA -- (Marketwired) -- 05/22/13 -- The world's top minds in medicine, science and business convened in San Francisco for the Third Annual Targeted Drug Delivery Conference. The conference provides a venue to stimulate collaboration on innovative treatments for patients suffering from neurological diseases such as Parkinson's, Alzheimer's and chronic pain. Direct delivery of therapies using...
Stryker Extends Co-Marketing Agreement With OrthoSensor(TM) Inc.
MAHWAH, NJ and SUNRISE, FL -- (Marketwired) -- 05/22/13 -- Stryker Corporation's Orthopaedics division and OrthoSensor, Inc., the leader in intelligent orthopedics, today announced an extension of their co-marketing agreement for Stryker's Triathlon Knee System and OrthoSensor's VERASENSE. VERASENSE is an intelligent instrument system that provides quantitative, intra-operative feedback to surg...
MELVILLE, NY--(Marketwired - May 22, 2013) - North American Partners in Anesthesia (NAPA), the largest single specialty anesthesia and perioperative management company in the United States, today announced New Jersey Anesthesia Group (NJAG), located in Paterson, NJ, has joined NAPA. With the addition of NJAG, NAPA continues its expansion in the New Jersey anesthesia market. An additional 73 NJAG...
WASHINGTON, DC -- (Marketwired) -- 05/22/13 -- The National Business Group on Health today honored 65 U.S. employers for their ongoing commitment to promoting healthy work environments and encouraging workers to live healthier lifestyles. The honored employers, including 12 first-time winners, were presented with "2013 Best Employers for Healthy Lifestyles®" awards at the Business Group's Instit...
Gorman Health Group and AIS Health Unveil Two New Webinars in Reality Check Series This June
WASHINGTON, DC--(Marketwired - May 22, 2013) - Gorman Health Group (GHG), the leading consulting firm and solutions provider in government health care programs, has announced exciting news for the month of June for anyone with a stake in government-sponsored health care. Two new webinars will be offered in the "Reality Check Series," an ongoing series of paid and complimentary webinars regardin...
Nuvilex, Inc. Could Become Significant Player in the Oncology Arena With Successful Phase III Trials
NEW YORK, NY -- (Marketwired) -- 05/22/13 -- Nuvilex, Inc. (OTCQB: NVLX) is a diamond in the rough in the truest sense. Currently shares of the Silver Spring, Maryland, biotechnology firm can be purchased for around 0.15/share allowing investors to build an incredible position in the company for what could be a blockbuster future. Don't expect these great prices to last forever though. According...
EnteroMedics to Participate in the Craig-Hallum Annual Institutional Investor Conference
ST. PAUL, MN -- (Marketwired) -- 05/22/13 -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company will participate in the Craig-Hallum Annual Institutional Investor Conference in Minneapolis, Minnesota to take place on May 29, 2013. The conferen...
Portola Announces Pricing of Initial Public Offering
SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/22/13 -- Portola Pharmaceuticals, Inc. announced today the pricing of its initial public offering of 8,422,758 shares of its common stock at a price to the public of $14.50 per share. All of the 8,422,758 shares are being offered by Portola. In addition, Portola granted the underwriters a 30-day over-allotment option to purchase up to an additional 1...
BioSyent Releases First Quarter Results-Sales Increase 70%, Profit Before Tax Up 76%
TORONTO, ONTARIO -- (Marketwired) -- 05/22/13 -- BioSyent Inc. (TSX VENTURE: RX) ("BioSyent") released today a summary of its First Quarter (Q1) 2013 financial results. Total sales for Q1 2013 of $1,541,843, were 70% higher compared to $904,488 in the corresponding prior year period. Net Income Before Tax for the first quarter of 2013 was $481,963, which is 76% higher than $273,184 in the firs...
GAINESVILLE, FL--(Marketwired - May 22, 2013) - Quick-Med Technologies, Inc. (OTCQB: QMDT), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that it has been awarded a contract by the U.S. Department of Defense for research on the "Development of Technologies to Control Scar Contracture after Burn Injuries." NIMBUS techno...
BC Pet Owners Have a New Weapon Against Dog Breath
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/22/13 -- A brand new, Canadian-made invention is officially in British Columbia now to help improve companion animals' oral hygiene and prevent bad breath. Kane Biotech Inc. (TSX VENTURE: KNE) is pleased to mark the official introduction of its StrixNB pet oral care product to the BC market today at Market Hill Animal Hospital in Vancouver. "Th...
Novadaq to Present at Jefferies 2013 Global Healthcare Conference
TORONTO, ONTARIO -- (Marketwired) -- 05/22/13 -- Novadaq® Technologies Inc. ("Novadaq" or the "Company") (TSX: NDQ)(NASDAQ: NVDQ), developer of clinically-relevant fluorescence imaging solutions for use in surgical and outpatient wound care procedures, today announced that Dr. Arun Menawat, the company's President and Chief Executive Officer, will present Novadaq's corporate overview at the Jef...
Alchemia Limited Provides Company Update
BRISBANE, AUSTRALIA -- (Marketwired) -- 05/22/13 -- Australian drug development company Alchemia Limited (ASX: ACL) today anounced the following updates regarding its marketed anticoagulant, fondaparinux; subsidary, Audeo's, HyACT platform; as well as its internal VAST drug discovery platform. Fondaparinux Profit Share Alchemia's international marketing partner Dr Reddy's Laboratories Limited (...
SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/21/13 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced the upcoming presentation of data highlighting Kyprolis® (carfilzomib) for Injection, a second-generation proteasome inhibitor, and oprozomib, an oral proteasome inhibitor in early development, at the 18th Congress of the European Hematology Association (EHA) Annual Meeting, June 13-...
SAN FRANCISCO, CA -- (Marketwired) -- 05/21/13 -- Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced that it completed enrollment of 120 patients in the TRAVERSE study, a global randomized Phase 2b clinical trial evaluating the efficac...
XYMOGEN Receives SMART Award for Corporate Excellence in Health Care and Life Sciences Industry
ORLANDO, FL--(Marketwired - May 21, 2013) - Orlando-based nutraceutical company XYMOGEN announced today that it is the recipient of the 2013 SMART award for corporate excellence in the health care and life sciences industry from the Orlando chapter of the Association for Corporate Growth (ACG). XYMOGEN is a family-owned, health-sciences company that researches, develops, and manufactur...
Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve
PARIS -- (Marketwired) -- 05/21/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that one-year data from its European post-approval study of the Edwards SAPIEN XT transcatheter aortic heart valve continued to demonstrate positive patient outcomes, including all-cause mortality and complication rates. D...
BrainStorm Provides Update on Clinical Trial and Scientific Conference Activities
NEW YORK, NY and PETACH TIKVAH, ISRAEL -- (Marketwired) -- 05/21/13 -- BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today provided an update on the company's current and upcoming clinical trial and scientific conference activities. Clinical Trial Activities Brainstorm recently performed the 5th transplantation in...
Novo Nordisk A/S - Share repurchase programme
BAGSVAERD, DENMARK -- (Marketwired) -- 05/21/13 -- On 3 May 2013, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules. This programme is part of the overall share repurchase programme of up to DKK 14.0 billion to be executed during a 12-month perio...
FRANKLIN, TN -- (Marketwired) -- 05/21/13 -- M*Modal, a leading provider of clinical documentation and Speech Understanding solutions, today announced an expanded relationship with Wellmont Health System to deliver exclusive enterprise-wide transcription, front-end speech recognition, workflow and reporting for electronic medical records (EMRs) and radiology systems. M*Modal Fluency Direct an...
Medistem, Inc. Appoints Herm Rosenman to Board of Directors
SAN DIEGO, CA -- (Marketwired) -- 05/21/13 -- Medistem, Inc. (PINKSHEETS: MEDS), today announced that it has appointed Herm Rosenman to its Board of Directors and Chairman of the Audit Committee. Mr. Rosenman was Senior Vice President and Chief Financial Officer of Gen-Probe, Inc., from 2001, through its IPO in 2002, until its acquisition by Hologic, Inc., in August 2012 for $3.7 billion. "We we...
BIOLASE Declares Stock Dividend for 2013 Second Quarter
IRVINE, CA -- (Marketwired) -- 05/21/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, announced today that its Board of Directors has declared a one-half percent stock dividend payable on June 28, 2013, to stockholders of record on June 14, 2013. About BIOLASE, Inc. BIOLASE, Inc. is a biomedical company that develops, manufactures, and market...
